Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Ajanta Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:532331NSE Symbol: AJANTPHARMP/E(TTM):37.05
ISIN Demat:INE031B01049Div & Yield %:1.05EPS(TTM):72.53
Book Value(Rs):290.2218799Market Cap ( Cr.):33569.5Face Value(Rs):2
    Change Company 
(Rs In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
SOURCES OF FUNDS :      
Share Capital 25.0725.2725.2717.1717.3917.54
Reserves Total 3600.243388.303221.183152.012867.592443.76
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds3625.313413.573246.453169.182884.982461.30
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 31.1730.5232.9020.4925.9123.49
Total Debt31.1730.5232.9020.4925.9123.49
Other Liabilities83.3243.2527.8323.4122.5219.78
Total Liabilities3739.803487.343307.183213.082933.412504.57
APPLICATION OF FUNDS :      
Gross Block 2759.582355.332246.282163.182086.541926.65
Less : Accumulated Depreciation 1017.62890.44762.27670.86567.75477.33
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 1741.961464.891484.011492.321518.791449.32
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress176.27256.45209.47152.86108.19131.06
Producing Properties0.000.000.000.000.000.00
Investments 481.84367.14553.26164.85156.8885.77
Current Assets, Loans & Advances      
Inventories 739.29677.79683.77635.11634.22436.19
Sundry Debtors 1225.811207.67977.631043.62782.30734.24
Cash and Bank49.7263.06269.92145.25151.9887.85
Loans and Advances 122.53163.10109.60111.17128.7289.66
Total Current Assets2137.352111.622040.921935.151697.221347.94
Less : Current Liabilities and Provisions      
Current Liabilities 663.96566.54874.39446.80459.91444.53
Provisions 39.9855.0625.5018.7446.5718.89
Total Current Liabilities703.94621.60899.89465.54506.48463.42
Net Current Assets1433.411490.021141.031469.611190.74884.52
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets37.2535.0034.3028.150.000.00
Deferred Tax Liability147.76143.50132.02130.0292.1781.16
Net Deferred Tax-110.51-108.50-97.72-101.87-92.17-81.16
Other Assets16.8317.3417.1335.3150.9835.06
Total Assets3739.803487.343307.183213.082933.412504.57
Contingent Liabilities8.124.944.557.2882.9050.13